ACP applauds CMS’ improved Medicare ACO Final rule The American University of Physicians today applauded CMS to make substantial improvements in its long – awaited Final Guideline on Accountable Care Companies . Based on its initial, preliminary analysis, ACP figured the changes can make it less complicated for internal medicine doctor specialists and other major care physicians to take part in this important effort to improve patient care through attempts to arrange an ACO or serve as a practice in another of these efforts.Lists the rates at which low, average, high, and very high cumulative annual effective doses were incurred in the analysis population. Moderate dosages were incurred at an annual price of 193.8 per 1000 enrollees, whereas high and incredibly high dosages were incurred at an annual price of 18.6 and 1.9 per 1000 enrollees, respectively. Each of these prices rose with advancing age group. For example, the annual rate of which high doses were incurred increased from 4.9 per 1000 enrollees among those 18 to 34 years to 52.7 per 1000 enrollees among those 60 to 64 years of age.